Back to results
Not yet recruitingPhase 2

Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab

NCT06371807

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fundaçao Champalimaud, Avenida Brasilia,

Lisbon, Portugal

+2 additional locations

View on ClinicalTrials.gov
Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab — TrialFind